Previous 10 | Next 10 |
2024-05-02 11:20:10 ET Moderna, Inc. (MRNA) Q1 2024 Earnings Conference Call May 02, 2024 08:00 A.M. ET Company Participants Lavina Talukdar - SVP & Head of IR Stéphane Bancel - CEO Stephen Hoge - President Jamey Mock - CFO Conference Call Part...
2024-05-02 10:18:21 ET The biotech sector includes companies that utilize biological processes to develop technologies and products for a wide range of industries. This includes healthcare, agriculture, and environmental management. These companies often focus on innovative therapies, medic...
2024-05-02 07:12:50 ET More on Moderna Moderna Investors Should Beware Patent-Dispute Fallout Moderna: Considering The Cancer Vaccine Angle Moderna Continues To Build A Pipeline Moderna GAAP EPS of -$3.07 beats by $0.50 Metagenomi, Moderna terminate g...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-05-02 06:36:59 ET More on Moderna Moderna Investors Should Beware Patent-Dispute Fallout Moderna: Considering The Cancer Vaccine Angle Moderna Continues To Build A Pipeline Metagenomi, Moderna terminate gene editing collaboration Moderna Q1 Earni...
2024-05-01 22:07:03 ET Summary Baillie Gifford's 13F portfolio value increased from ~$126B to ~$129B this quarter. The top three holdings in the portfolio are NVIDIA, MercadoLibre, and Amazon.com. Baillie Gifford made stake increases in Coupang, Meta Platforms, NU Holdings, an...
2024-05-01 16:56:15 ET More on Metagenomi, Inc. Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps Jefferies, BMO bullish on newly public Metagenomi Moderna-backed Metagenomi sees stock fall 31% after $94M IPO Historical earnings data fo...
2024-05-01 14:02:37 ET Moderna ( NASDAQ: MRNA ) is scheduled to announce Q1 earnings results on Thursday, May 2nd, before market open.... Read the full article on Seeking Alpha For further details see: Moderna Q1 Earnings Preview: Focus on pipeline, costs
2024-04-30 15:03:39 ET Summary The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year. There are two key items that will determine the direction of small and midcap biotech sto...
2024-04-28 08:00:00 ET As the calendar flips from April to May, the upcoming week is set to bring a flurry of earnings reports from some of the world's most prominent companies. At the top of the list, updates are anticipated from tech giants Amazon ( NASDAQ: AMZN ) and Apple ( NA...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...